LYRA

LYRA

USD

Lyra Therapeutics Inc. Common Stock

$12.830-0.500 (-3.751%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$13.330

高値

$13.502

安値

$11.670

出来高

0.20M

企業ファンダメンタルズ

時価総額

17.0M

業種

バイオテクノロジー

United States

取引統計

平均出来高

0.65M

取引所

NCM

通貨

USD

52週レンジ

安値 $3.81現在値 $12.830高値 $37.5

関連ニュース

Analyst Upgrades

HC Wainwright & Co. Maintains Neutral on Lyra Therapeutics, Raises Price Target to $16

HC Wainwright & Co. analyst Matthew Caufield maintains Lyra Therapeutics with a Neutral and raises the price target from $2 to $16.

もっと見る
HC Wainwright & Co. Maintains Neutral on Lyra Therapeutics, Raises Price Target to $16
GlobeNewswire

Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)

ENLIGHTEN 2 trial met primary endpoint with LYR-210 demonstrating statistically significant improvement in the composite of the three cardinal symptoms (3CS) of CRS at 24 weeks (p=0.0078)ENLIGHTEN 2 trial also showed

もっと見る
Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)